Clinical Trials Logo

Clinical Trial Summary

This study is a multicenter, open-label, observational, postmarketing surveillance study that will collect information on the use of Genentech GH preparations to treat GH-deficient subjects with optimal GH dosing during puberty.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00097513
Study type Observational
Source Genentech, Inc.
Contact
Status Completed
Phase Phase 4
Start date February 2003
Completion date June 2006

See also
  Status Clinical Trial Phase
Recruiting NCT02314676 - Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children Phase 4
Completed NCT01187550 - Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen® Phase 4
Completed NCT00102258 - Role of Nutrition and Hormones in Boys With Disordered Growth Phase 2
Completed NCT00097526 - Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD) Phase 4